These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 5843362)

  • 21. [ON THE KNOWLEDGE OF NEUROMYOPATHIA CARCINOMATOSA WITH MYASTHENIC SYNDROME].
    CANAK S; JANTSCH H; KUCHER R; LILL K; PATEISKY K; STEINBEREITHNER K
    Anaesthesist; 1964 Mar; 13():65-9. PubMed ID: 14175180
    [No Abstract]   [Full Text] [Related]  

  • 22. [The action of hydantoinate in the organism during the therapy of epilepsy with special reference to the origin of gingival hyperplasia. Review II].
    Drizhal I; Hrdinová V
    Cesk Stomatol; 1972 May; 72(3):196-203. PubMed ID: 4557039
    [No Abstract]   [Full Text] [Related]  

  • 23. [Oral changes due to hydantoin].
    Nejad RH
    J Dent Sch Natl Univ Iran; 1977 Jan; 8(2):7-15, 77. PubMed ID: 267142
    [No Abstract]   [Full Text] [Related]  

  • 24. [Case of myasthenic syndrome associated with lung cancer].
    Tanaka H; Kawabata T; Kono Y; Sakamoto F; Takeda M
    Naika; 1969 Oct; 24(4):771-6. PubMed ID: 5358687
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of edrophonium on saccadic velocity in normal subjects and myasthenic and nonmyasthenic ocular palsies.
    Barton JJ; Huaman AG; Sharpe JA
    Ann Neurol; 1994 Oct; 36(4):585-94. PubMed ID: 7944291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Fetal diseases due to hydantoin. Description of a case].
    Nicoletti I; Mariotti G; Filipponi P; Serena Lungarotti M
    Minerva Pediatr; 1980 Jan; 32(1):61-4. PubMed ID: 6789050
    [No Abstract]   [Full Text] [Related]  

  • 27. [Neonatal myasthenia gravis].
    Belasco C; Carbillon L; Louaib D; Gaudelus J; Uzan M
    Arch Pediatr; 2000 Mar; 7(3):263-6. PubMed ID: 10761602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Leukaemia following hydantoin treatment].
    Wildhack R
    Munch Med Wochenschr; 1973 Jul; 115(28):1275-9. PubMed ID: 4516331
    [No Abstract]   [Full Text] [Related]  

  • 29. Development of myasthenia gravis after interferon alpha therapy.
    Gurtubay IG; Morales G; Aréchaga O; Gállego J
    Electromyogr Clin Neurophysiol; 1999 Mar; 39(2):75-8. PubMed ID: 10207675
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Ocular myasthenic syndrome and systemic lupus erythematosus].
    Budde M; Heckmann JG; Kraus B; Gusek-Schneider GC
    Klin Monbl Augenheilkd; 2002 Jul; 219(7):537-9. PubMed ID: 12195322
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autosomal recessive limb girdle myasthenia in two sisters.
    Shankar A; Solomon T; Joseph TP; Gnanamuthu C
    Neurol India; 2002 Dec; 50(4):500-3. PubMed ID: 12577107
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myasthenic diseases and related physiology.
    Howard FM
    Arch Phys Med Rehabil; 1966 Mar; 47(3):137-46. PubMed ID: 5904918
    [No Abstract]   [Full Text] [Related]  

  • 33. A diagnostic and management dilemma: combined paraneoplastic myasthenia gravis and Lambert-Eaton myasthenic syndrome presenting as acute respiratory failure.
    Roohi F; Smith PR; Bergman M; Baig MA; Sclar G
    Neurologist; 2006 Nov; 12(6):322-6. PubMed ID: 17122730
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hydantoin-induced teratogenesis: are arene oxide intermediates really responsible?
    Finnell RH; DiLiberti JH
    Helv Paediatr Acta; 1983 May; 38(2):171-7. PubMed ID: 6135678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neonatal hemorrhage secondary to thrombocytopenia: an occasional effect of prenatal hydantoin exposure.
    Page TE; Hoyme HE; Markarian M; Jones KL
    Birth Defects Orig Artic Ser; 1982; 18(3 Pt A):47-54. PubMed ID: 7126797
    [No Abstract]   [Full Text] [Related]  

  • 36. [Hydantoin poisoning: clinical aspects, laboratory parameters and EEG].
    Körner E; Ladurner G; Enge S; Lechner H
    Nervenarzt; 1983 Oct; 54(10):548-52. PubMed ID: 6646292
    [No Abstract]   [Full Text] [Related]  

  • 37. Decrement pattern in Lambert-Eaton myasthenic syndrome is different from myasthenia gravis.
    Baslo MB; Deymeer F; Serdaroglu P; Parman Y; Ozdemir C; Cuttini M
    Neuromuscul Disord; 2006 Jul; 16(7):454-8. PubMed ID: 16806929
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medical therapies in myasthenia gravis.
    Younger DS; Raksadawan N
    Chest Surg Clin N Am; 2001 May; 11(2):329-36. PubMed ID: 11413759
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Melanotic neuroectodermal tumor of infancy and fetal hydantoin syndrome.
    Jimenez JF; Seibert RW; Char F; Brown RE; Seibert JJ
    Am J Pediatr Hematol Oncol; 1981; 3(1):9-15. PubMed ID: 6263127
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Mixedema in an epileptic patient caused by the administration of dimethyl-dithyol-hydantoin: our first experience on the use dimethyl-dithyol-hydantoin in hyperthyroidism].
    RUIZ REY A
    Rev Clin Esp; 1954 Feb; 52(3):178-86. PubMed ID: 13178171
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.